CAR T therapy turns patient’s T-cells into cancer killers
FDA-approved treatment so new that many oncologists are unfamiliar with it
Bradford Neveu, 31, is currently undergoing CAR T-cell therapy at Methodist University Hospital. (Patrick Lantrip/Daily Memphian)
A new cancer treatment is giving lymphoma patients who are not responsive to chemotherapy another option than hospice care.
Topics
cancer CAR T-cell therapy Dr. Salil Goorha Dr. Yasser Khaled Methodist Le Bonheur HealthcareMichelle Corbet
Michelle Corbet covers business for The Daily Memphian. Prior to, she was a reporter at the Memphis Business Journal. A native Memphian and University of Memphis graduate, Michelle covered business in Conway, Arkansas after college. Michelle got her start covering business as an intern at The Commercial Appeal.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.